Blog

Gene therapy developer Orchard Therapeutics raises $110 million – Reuters


FierceBiotech

Gene therapy developer Orchard Therapeutics raises $110 million
Reuters
On Tuesday, the health agency approved Spark Therapeutics Inc's treatment for a rare form of blindness, marking the first time the agency has approved a gene therapy for an inherited disease. ADA-SCID is an inherited disorder that damages the immune
Orchard raises $110M to bring gene therapy to marketFierceBiotech



all 3 news articles »

2017-12-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.